Abstract:Objective To explore the effects of hTRX and PR39 as target genes on cerebral ischemic disease,and to construct a fusion gene of hTRX-PR39 cDNA.Methods The forward and reverse primers of PR39 were designed and synthesized.By means of PCR,the fragment encoding PR39 was gained,including EcoR721 and BamH I restriction enzyme sites,and the new hTRX cDNA including EcoR721 and EcoRI restriction enzyme sites was also gained.Then the synthesized fragments were easily cloned into vector pGEM-T.The positive clone was identified by restriction enzymes,and then the cloned amplified fragments were sequenced by the dideoxy-mediated chain-termination method.The cloned hTRX and PR39 cDNA were compared with the GeneBank sequence by the DNASIS.After pGEM-T-hTRX and pGEM-T-PR39 were both digested by BamH I and EcoRI,the PR39/BamHI,EcoRI was cloned into the recombinant vector pGEM-T-hTRX/BamHI,EcoRI.The recombinant vector pGEM-T-hTRX-PR39 was gained.Results Sequences of modified hTRX and PR39 were consistent with those of the gene bank.After analyzing the ORF of the cloned hTRX-PR39 cDNA by the DNASIS,we found that amino acids encoded by the cloned hTRX-PR39 cDNA were identical to published results.Conclusion The sequence of hTRX including EcoR721 and EcoRI restriction enzyme sites and sequence of PR39 including EcoR721 and BamH I restriction enzyme sites were successfully obtained by PCR.Also,the recombinant vector pGEM-T-hTRX-PR39 was successfully constructed.

Construction and Identification of Recombinant Plasmids Expressing Htrx-Pr39